CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Author
A Liebow
A Rossum Van
+55Â more
AC Komor
B Hoppe
B Hoppe
BB Beck
C Dutta
C Lai
C Long
C Martin-Higueras
C Vignaud
CE Nelson
CJ Danpure
D Katrekar
DBT Cox
E Leumann
E Salido
E Salido
EC Salido
EJ Bergstralh
FA Ran
FA Ran
FP Pankowicz
G Petris
H Li
H Lindsay
H Yin
J Harambat
J Jiang
JG Doench
K Hopp
K Nakajima
KE Jarrett
L Cai
L Cong
M Cavaco
M Tabebordbar
M Wang
N Merienne
N Miyata
NP Clayton
O Clifford-Mobley
O Murillo
P Cochat
P Cochat
P Mali
S Fargue
SA Syed Haneef
T Gaj
V Iyer
VO Edvardsson
W Yu
WC Lamanna
WL Chew
Y Frishberg
Y Yang
Z Yan
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref